Clinical trials
Completed Phase 1 Nervous System Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Siena Biotech S.p.A. | 2 |
| Ceres Brain Therapeutics | 1 |
| Cerevel Therapeutics, LLC | 1 |
| Contineum Therapeutics | 1 |
| DNAtrix, Inc. | 1 |
| Edgewise Therapeutics, Inc. | 1 |
| Forest Hills Lab | 1 |
| Johns Hopkins University | 1 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 1 |
| Neurocrine Biosciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nervous System Diseases | 16 |
| Central Nervous System Diseases | 7 |
| Brain Diseases | 6 |
| Movement Disorders | 6 |
| Neurodegenerative Diseases | 5 |
| Genetic Diseases, Inborn | 4 |
| Basal Ganglia Diseases | 3 |
| Dementia | 3 |
| Heredodegenerative Disorders, Nervous System | 3 |
| Mental Disorders | 3 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.